Stéphane De Lombaert

1.6k total citations
49 papers, 1.2k citations indexed

About

Stéphane De Lombaert is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Stéphane De Lombaert has authored 49 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 16 papers in Physiology and 14 papers in Organic Chemistry. Recurrent topics in Stéphane De Lombaert's work include Nitric Oxide and Endothelin Effects (13 papers), Peptidase Inhibition and Analysis (9 papers) and Neuropeptides and Animal Physiology (7 papers). Stéphane De Lombaert is often cited by papers focused on Nitric Oxide and Endothelin Effects (13 papers), Peptidase Inhibition and Analysis (9 papers) and Neuropeptides and Animal Physiology (7 papers). Stéphane De Lombaert collaborates with scholars based in United States, Switzerland and France. Stéphane De Lombaert's co-authors include Arco Y. Jeng, Angelo J. Trapani, Louis Blanchard, Léon Ghosez, Jenny Tan, Alison Kukulka, Neil A. Farrow, Yumi Sakane, Anne B. Eldrup and Carol Berry and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Stéphane De Lombaert

49 papers receiving 1.1k citations

Peers

Stéphane De Lombaert
Xavier de Leval Belgium
Hélène Jûteau Canada
Jeffrey A. Robl United States
David A. Claremon United States
John D. Elliott United States
Deirdre M. B. Hickey United Kingdom
Yoshiyuki Inada Japan
Sung‐Eun Yoo South Korea
Korekiyo Wakitani Japan
Robert J. Ife United Kingdom
Xavier de Leval Belgium
Stéphane De Lombaert
Citations per year, relative to Stéphane De Lombaert Stéphane De Lombaert (= 1×) peers Xavier de Leval

Countries citing papers authored by Stéphane De Lombaert

Since Specialization
Citations

This map shows the geographic impact of Stéphane De Lombaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane De Lombaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane De Lombaert more than expected).

Fields of papers citing papers by Stéphane De Lombaert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane De Lombaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane De Lombaert. The network helps show where Stéphane De Lombaert may publish in the future.

Co-authorship network of co-authors of Stéphane De Lombaert

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane De Lombaert. A scholar is included among the top collaborators of Stéphane De Lombaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane De Lombaert. Stéphane De Lombaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goldberg, Daniel R., Stéphane De Lombaert, Robert J. Aiello, et al.. (2016). Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(3). 413–419. 29 indexed citations
2.
Goldberg, Daniel R., Stéphane De Lombaert, Robert J. Aiello, et al.. (2016). Discovery of acyl guanidine tryptophan hydroxylase-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(12). 2855–2860. 11 indexed citations
3.
Taylor, Steven J., Anil K. Padyana, Shuang Liang, et al.. (2013). Discovery of Potent, Selective Chymase Inhibitors via Fragment Linking Strategies. Journal of Medicinal Chemistry. 56(11). 4465–4481. 23 indexed citations
4.
Kim, Jin‐Man, Ming‐Hong Hao, Kevin Qian, et al.. (2011). Benzimidazolone as potent chymase inhibitor: Modulation of reactive metabolite formation in the hydrophobic (P1) region. Bioorganic & Medicinal Chemistry Letters. 21(15). 4533–4539. 16 indexed citations
5.
Taylor, Steven J., Anne B. Eldrup, Neil A. Farrow, et al.. (2009). Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase. Bioorganic & Medicinal Chemistry Letters. 19(20). 5864–5868. 16 indexed citations
6.
Eldrup, Anne B., et al.. (2009). Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase. Bioorganic & Medicinal Chemistry Letters. 20(2). 571–575. 32 indexed citations
7.
Blum, Charles A., Xiaozhang Zheng, Harry L. Brielmann, et al.. (2008). Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution. Bioorganic & Medicinal Chemistry Letters. 18(16). 4573–4577. 13 indexed citations
8.
Cook, Brian N., Jörg Bentzien, André White, et al.. (2008). Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design. Bioorganic & Medicinal Chemistry Letters. 19(3). 773–777. 29 indexed citations
9.
Yoon, Tae‐young, Stéphane De Lombaert, Robbin Brodbeck, et al.. (2008). 2-Arylpyrimidines: Novel CRF-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 18(16). 4486–4490. 8 indexed citations
10.
Hodgetts, Kevin J., Tae‐young Yoon, Jianhua Huang, et al.. (2003). 2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 13(15). 2497–2500. 14 indexed citations
11.
Yuan, Jun, et al.. (2002). 3-Aryl pyrazolo[4,3-d]pyrimidine derivatives. Bioorganic & Medicinal Chemistry Letters. 12(16). 2133–2136. 30 indexed citations
12.
Trapani, Angelo J., Stéphane De Lombaert, Michael E. Beil, et al.. (2000). Cgs 34043. Life Sciences. 67(9). 1025–1033. 10 indexed citations
13.
Jeng, Arco Y., Stéphane De Lombaert, Michael E. Beil, et al.. (2000). Design and Synthesis of a Potent and Selective Endothelin-Converting Enzyme Inhibitor, CGS 35066. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S36–S39. 19 indexed citations
14.
Trapani, Angelo J., Michael E. Beil, Charles W. Bruseo, Stéphane De Lombaert, & Arco Y. Jeng. (2000). Pharmacological Properties of CGS 35066, a Potent and Selective Endothelin-Converting Enzyme Inhibitor, in Conscious Rats. Journal of Cardiovascular Pharmacology. 36(Supplement 1). S40–S43. 17 indexed citations
15.
Savage, Paula, Stéphane De Lombaert, Kohei Shimada, Kazuhiko Tanzawa, & Arco Y. Jeng. (1998). Differential Inhibition of Wild-Type Endothelin-Converting Enzyme-1 and Its Mutants. Journal of Cardiovascular Pharmacology. 31. S16–S18. 2 indexed citations
16.
Trapani, Angelo J., et al.. (1998). Antihypertensive and Natriuretic Effects of CGS 30440, a Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral Endopeptidase 24.11. Journal of Pharmacology and Experimental Therapeutics. 284(3). 974–982. 18 indexed citations
17.
Lombaert, Stéphane De, Louis Blanchard, Jenny Tan, et al.. (1997). Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11. Bioorganic & Medicinal Chemistry Letters. 7(8). 1059–1064. 26 indexed citations
18.
Lombaert, Stéphane De, et al.. (1996). Design and Pharmacology of Dual Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitors. Current Pharmaceutical Design. 2(5). 443–462. 9 indexed citations
19.
Trapani, Angelo J., et al.. (1995). Inhibition of Big ET-1-Induced Pressor Response by an Orally Active Dual Inhibitor of Endothelin-Converting Enzyme and Neutral Endopeptidase 24.11. Journal of Cardiovascular Pharmacology. 26. S69–71. 20 indexed citations
20.
Lombaert, Stéphane De, Mark D. Erion, Jenny Tan, et al.. (1994). N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11) Inhibitors. Journal of Medicinal Chemistry. 37(4). 498–511. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xavier de Leval Breakdown of academic impact, for papers by Hélène Jûteau Breakdown of academic impact, for papers by Jeffrey A. Robl Breakdown of academic impact, for papers by David A. Claremon Breakdown of academic impact, for papers by John D. Elliott Breakdown of academic impact, for papers by Deirdre M. B. Hickey Breakdown of academic impact, for papers by Yoshiyuki Inada Breakdown of academic impact, for papers by Sung‐Eun Yoo Breakdown of academic impact, for papers by Korekiyo Wakitani Breakdown of academic impact, for papers by Robert J. Ife
Rankless by CCL
2026